Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss

Hans Lamm; Claus Müller-Kortkamp; Athanasia Warnecke; Friederike Pohl; Gerrit Paasche; Thomas Lenarz; Stefan R O Stolle

doi:10.1002/ccr3.510

Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss

Clin Case Rep. 2016 Feb 11;4(3):287-93. doi: 10.1002/ccr3.510. eCollection 2016 Mar.

Authors

Hans Lamm¹, Claus Müller-Kortkamp², Athanasia Warnecke³, Friederike Pohl¹, Gerrit Paasche³, Thomas Lenarz³, Stefan R O Stolle¹

Affiliations

¹ Department of Otorhinolaryngology Hannover Medical School Carl-Neuberg-Str. 1 Hannover 30625 Germany.
² Private Practice for Otorhinolaryngology Institute of Hyperbaric Medicine Seilerstr. 7-9 Hannover 29614 Germany.
³ Department of Otorhinolaryngology Hannover Medical School Carl-Neuberg-Str. 1 Hannover 30625 Germany; Hearing 4 all Cluster of Excellence Hannover Germany.

Abstract

Concurrent hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) are beneficial as salvage therapy for therapy-refractory sudden sensorineural hearing loss (SSNHL). The findings encourage further research on the treatment of noise-induced and idiopathic SSNHL with concurrent use of HBOT and ITS respecting also patients with long-term or therapy-refractory SSNHL.

Keywords: Concurrent hyperbaric oxygen therapy; intratympanic steroid application; sudden deafness; sudden sensorineural hearing loss.

Publication types

Case Reports